Design and implementation of an inpatient disease management program.
OBJECTIVE
To describe the development and implementation of an inpatient disease management program.


METHODS
Prospective observational study.


METHODS
On the basis of opportunities for improving quality or efficiency of inpatient and emergency department care, 4 diagnoses, including congestive heart failure (CHF), gastrointestinal hemorrhage, community-acquired pneumonia and sickle-cell crisis were selected for implementation of a disease management program. For each diagnosis, a task force assembled a disease management team led by a "physician champion" and nurse care manager and identified opportunities for improvement through medical literature review and interviews with caregivers. A limited number of disease-specific guidelines and corresponding interventions were selected with consensus of the team and disseminated to caregivers. Physician and nurse team leaders were actively involved in patient care to facilitate adherence to guidelines.


RESULTS
For quarter 2 to 4 of 1997, there were improvements in angiotensin-converting enzyme inhibitor use, daily weight compliance, assessment of left ventricular function, hospital costs, and length of stay for care-managed patients with CHF. Differences in utilization-related outcomes persisted even after adjustment for severity of illness. For the other 3 diagnoses, the observational period was shorter (quarter 4 only), and hence preliminary data showed similar hospital costs and length of stay for care-managed and noncare-managed patients.


CONCLUSIONS
An interdisciplinary approach to inpatient disease management resulted in substantial improvements in both quality and efficiency of care for patients with CHF. Additional data are needed to determine the program's impact on outcomes of other targeted diagnoses.
Cooper
G S
GS
Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University School of Medicine, Cleveland, OH, USA. gxc12@po.cwru.edu
Armitage
K B
KB
Ashar
B
B
Costantini
O
O
Creighton
F A
FA
Raiz
P
P
Wong
R C
RC
Carlson
M D
MD
D000046:Academic Medical Centers / Q000191:economics* / Q000706:statistics & numerical data; D000755:Anemia, Sickle Cell / Q000191:economics* / Q000628:therapy; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000191:economics; D003363:Cost Control; D019468:Disease Management; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000191:economics*; D019983:Guideline Adherence; D006333:Heart Failure / Q000191:economics* / Q000628:therapy; D017721:Hospital Costs / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay; D009820:Ohio; D010146:Pain / Q000188:drug therapy; D010348:Patient Care Team; D011014:Pneumonia / Q000188:drug therapy / Q000191:economics*; D017410:Practice Guidelines as Topic; D016730:Program Development; D015397:Program Evaluation; D011446:Prospective Studies; D011785:Quality Assurance, Health Care